OptiGel® Mini Technology

INNOVATIVE ORAL SOFTGEL PLATFORM THAT DELIVERS FULL STRENGTH APIS IN A SMALL, POWERFUL SOFTGEL

Technical Advantages Consumer Benefits Catalent Development Expertise Facilities

As the leading innovator of softgel technology, Catalent has developed the next generation in softgels that deliver full strength efficacy in a smaller capsule size more preferred by patients and consumers.

TECHNICAL ADVANTAGES

Enables higher API concentrations in smaller capsules
Helps improve absorption and permeability
Improves performance of compounds in lipophilic and hydrophilic formulations
A solutions for complex API formulation and development issues
Capable of delivering single and combination API formulations
Tamper evident

CONSUMER BENEFITS

Full strength efficacy in approximately 30% smaller capsule than traditional softgels
Improves compliance, especially for seniors and children
Versatile softgel options available in variety of colors, shapes, sizes, and clarity

CATALENT DEVELOPMENT EXPERTISE

Preformulation and feasibility studies
Solubility screening of NCEs
Softgel capsule fill formulation development
Small-scale lab encapsulation for providing early stability data and final formulation selection
Shell development
- An extensive shell library, which enables us to offer a wide variety of options for a range of products
- A large range of shell gelatin and non-gelatin formula possibilities and compatibility concerns
IP (intellectual property) positions including fill formulations for improved bioavailability
Extensive technical support in softgel capsule product development
- Self-emulsifying/micro emulsion vehicle systems
- Unique formulations potentially leading to patentable line extensions
Reliable supply from clinical phases to commercial manufacturing
Contingency planning and quality assurance via our large global network

FACILITIES

All of our sites are subject to annual review so we can remain in compliance with cGMP, FDA, EMA, and locally accredited softgel facilities.